SKI II
CAS No. 312636-16-1
SKI II ( SKI-II; SKI II. Sphingosine kinase inhibitor II )
Catalog No. M18409 CAS No. 312636-16-1
SKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 35 | In Stock |
|
10MG | 51 | In Stock |
|
25MG | 97 | In Stock |
|
50MG | 168 | In Stock |
|
100MG | 294 | In Stock |
|
200MG | 530 | In Stock |
|
500MG | 849 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSKI II
-
NoteResearch use only, not for human use.
-
Brief DescriptionSKI II is a highly selective and non-ATP-competitive S1P receptor inhibitor (IC50: 0.5 μM) while exhibiting no inhibitory action on other kinases including PKCα, PI3K, and ERK2.
-
DescriptionSKI-II is a selective non-lipid inhibitor of sphingosine kinase (IC50 = 0.5 μM). nhibits acute myelogenous leukemia cell growth in vitro and in vivo. SKI-II was more efficient than two known SphK1 inhibitors SK1-I and FTY720 in inhibiting AML cells. Meanwhile, it induced dramatic apoptosis in above AML cells, and the cytotoxicity by SKI-II was almost reversed by the general caspase inhibitor z-VAD-fmk. SKI-II treatment inhibited SphK1 activation, and concomitantly increased level of sphingosine-1-phosphate (S1P) precursor ceramide in AML cells.
-
SynonymsSKI-II; SKI II. Sphingosine kinase inhibitor II
-
PathwayOthers
-
TargetOther Targets
-
RecptorSphK1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number312636-16-1
-
Formula Weight302.78
-
Molecular FormulaC15H11ClN2OS
-
Purity98%
-
SolubilityDMSO : ≥ 100 mg/mL; 330.27 mM
-
SMILESc1cc(ccc1c1csc(n1)Nc1ccc(cc1)O)Cl
-
Chemical Name4-[[4-(4-Chlorophenyl)-2-thiazolyl]amino]phenol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. French KJ, et al. Y Res, 2003, 63(18), 5962-5969.
molnova catalog
related products
-
Yinxiancaoside C
Yinxiancaoside C has antitumor effect.
-
Ligustroflavone
Ligustroflavone has anti-inflammatory activity.
-
DTP3
DTP3 is a selective MKK7/GADD45β inhibitor, which inhibits cancer-selective NF-κB survival pathway.